Optimising Skin Health with Wearable Diabetes Technology
For individuals living with diabetes, wearable technologies like such as continuous glucose monitors (CGMs) and insulin pumps are transformative tools that simplify disease management. However, for 25–40% of users, skin reactions present a common yet underappreciated challenge. Studies reveal that nearly 28–29% of users experience issues like redness and itching, with prevalence rising above 40% in paediatric populations. These figures underscore the critical need for proactive management strategies, particularly for vulnerable groups.1
Beyond the physical discomfort, skin reactions significantly impact emotional well-being and quality of life, especially in children and teens. Youth dealing with skin issues report a heightened emotional burden, which can complicate their diabetes management routines. Early prevention and targeted interventions are crucial to addressing these challenges effectively.2
This article explores the skin reactions associated with wearable diabetes technology, their risk factors, and evidence-based strategies for prevention and management. With guidance, your patients can better navigate these issues and have a better treatment experience.
These topics are discussed further by HCP experts in the webinar linked below.